John Johnson Insider Profile

4 Followers
John Johnson, CEO, Director at Melinta Therapeutics, holds 37.40K shares in Melinta Therapeutics (Ticker: MLNTQ), holds ― shares in AVEO Pharma (Ticker: AVEO), holds 522.15K shares in Strongbridge Biopharma (Ticker: SBBP). Most recently, John Johnson Sold ― shares of Melinta Therapeutics on Jul 02, 2019 for an estimated value of 72.41K.
tipranks
John Johnson

John Johnson
Melinta Therapeutics (MLNTQ)
CEO, Director

Ranked #6,857 out of 78,624 Corporate Insiders

Profitable Transactions

67%
2 out of 3 Profitable Transactions

Average Return

+118.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
100.00%
0.00%
0.00%
0.00%
0.00% Others
A breakdown of John Johnson's holdings

Insider Roles

Strongbridge Biopharma
(SBBP)
CEO, Director
AVEO Pharma
(AVEO)
Director
Verastem
(VSTM)
Director
Ocugen
(OCGN)
Director
+1 other positions
Roles that John Johnson holds in companies

Most Profitable Insider Trade

Stock:
Melinta Therapeutics
(MLNTQ)
Rating:Informative Buy
Date:May 28, 2014 - May 28, 2015
Return:+297.50%
The most profitable trade made by John Johnson

John Johnson's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
MLNTQ
Melinta Therapeutics
Jul 02, 2019
Informative Sell
72.41K
$4.11K
AVEO Pharma
Director
Strongbridge Biopharma
Jul 07, 2020
CEO, Director
Uninformative Buy
$1.44M
Verastem
Director
SCMP
Sucampo Pharmaceuticals
Feb 13, 2018
Uninformative Sell
92.34K
$0.00
PTLA
Portola Pharma
Jul 02, 2020
Uninformative Sell
237.49K
$0.00
Ocugen
Director
$0.00
DNDNQ
Dendreon Corp
Jul 08, 2014
Uninformative Sell
27.69K
Eli Lilly & Co
Sr. VP, Oncology Business Unit
$0.00
SVNTQ
Savient Pharmaceuticals
Feb 02, 2011
Uninformative Buy
OCRX
Ocera Therapeutics
$0.00
List of latest transactions for each holding click on a transaction to see John Johnson's performance on stock

John Johnson insider profile FAQ

What is the percentage of profitable transactions made by John Johnson?
The percentage of profitable transactions made by John Johnson is 67%.
    What is the average return per transaction made by John Johnson?
    The average return per transaction made by John Johnson is 118.80%.
      What stocks does John Johnson hold?
      John Johnson holds: MLNTQ, AVEO, SBBP, VSTM, SCMP, PTLA, OCGN, DNDNQ, LLY, SVNTQ, OCRX stocks.
        What was John Johnson’s latest transaction?
        John Johnson latest transaction was an Informative Sell of $72.41K.
          What was John Johnson's most profitable transaction?
          John Johnson’s most profitable transaction was an Informative Buy of MLNTQ stock on May 28, 2014. The return on the trade was 297.50%.
            What is John Johnson's role in Melinta Therapeutics?
            John Johnson's role in Melinta Therapeutics is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.